Home › NDC Lookup › Ingredients › Water › 00409-4887-10
Sterile Water 1 mL/mL Injection — NDC 00409-4887-10 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Sterile Water 1 mL/mL Injection — NDC 0409-4887-10 (Billing 00409-4887-10)

by Hospira, Inc. · 25 VIAL, PLASTIC in 1 TRAY / 10 mL in 1 VIAL, PLASTIC

This is a package of Sterile Water 1 mL/mL Injection from Hospira, Inc., marketed since Jun 2005 and currently FDA-listed; retail pharmacies pay about $0.3150 per mL (NADAC). It is the main listing for this product, which comes in 5 package sizes.

NDC 00409-4887-10
🏷️ FDA NDC (as labeled) 0409-4887-10 billing pads the labeler segment with a zero
This package
Contains10 mL in 1 vial, plastic Cost per mL$0.3150 NADAC Per package$78.75 / 250 ml Pack sizes5 compare ↓
Also priced by: Medicaid pays $4.29/unit — full pricing hub ↓
Main listing for product 0409-4887 · Also comes in: 25 vials 0409-4887-20 25 vials 0409-4887-50 25 vials 0409-4887-99 30 vials 0409-4887-34
Rx only Brand On market Non-controlled ⚠ On shortage ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 0409-4887-10 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
0409 labeler · 4887 product · 10 package
Package marketed since
Aug 1, 2005
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC-A, from the NDC)
3 0409488710 4
Medicaid fills, this package
16,888 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026
⚠️
Active FDA shortage. Sterile Water Injection is currently reported in shortage by the FDA. Available Shortage details →
⚠️
Other active recalls for Water (different manufacturers) — 3 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Apr 2, 2026 — Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed. (B BRAUN MEDICAL INC) · FDA recall D-0495-2026
Class II · Dec 22, 2025 — Presence of particulate matter: plastic particles from the bottle rim were observed floating into the solution (Baxter Healthcare Corporation) · FDA recall D-0296-2026
Class II · Aug 26, 2025 — Lack of Assurance of Sterility- Potential for fluid leakage from the port due to port misalignment. (B BRAUN MEDICAL INC) · FDA recall D-0652-2025
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0409-4887-10
Product NDC 0409-4887
11-digit billing NDC 00409488710
NCPDP billing unit ML — per mL (volume)
UNII 059QF0KO0R
Application # NDA018801
SPL Set ID 2b9ea23a-f9e9-48a8-25b7-519e3bbd6828
DEA schedule Non-controlled
Marketing category NDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2005-06-16
Route INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage form INJECTION
Substance WATER

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 98401010002000
GPI class Sterile Water for Injection
GCN Seq No 001167
GCN 02709
HICL code 000517
Ingredient (HICL) Water For Injection,Sterile
HIC1 code C
Therapeutic class — broad (HIC1) Electrolyte Balance/Metabolism/Nutrition
HIC2 code C0
Therapeutic class — intermediate (HIC2) Affect Fluid/Acid-Base Balance/Metabolic Systems
HIC3 code C0B
Therapeutic class — specific (HIC3) Water
AHFS code 96:00.00.00
AHFS class Pharmaceutical Aids
FDB label name WATER FOR INJECTION VIAL
FDB brand name Water
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 001167
  • GCN: 02709
  • GPI-14 (Medi-Span): 98401010002000
  • HICL (First Databank): 000517
  • AHFS class code: 96:00.00.00
Why two NDCs? The FDA registers this code as 0409-4887-10 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00409-4887-10. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name WATER FOR INJECTION VIAL Ingredient Water For Injection,Sterile
📗 Our plain-language guide HelloPharmacist
  • It can seem a little odd at first. In these products, sterile water plays the essential role of carrying or dissolving the actual active medication — like insulin — so it can be sa...
  • Why is 'water' listed as the active ingredient on my medicine?
  • No — these are very different products that should never be used interchangeably. Sterile Water for Injection is used only as a diluent for other drugs given by needle, and it must...
  • Is Sterile Water for Injection the same as the eye wash or the irrigation product?
📖 Read our full Water guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.315 $78.75 / 250 ml
Medicaid paysCMS SDUD · 12 mo $4.29 $1,072.10 / 250 ml
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
Medicare Part B allowsASP · A4216 No ASP payment limit on file for A4216 this quarter.
NADAC price history (per mL) — tap or hover for the price & month
May 2022 Jan 2026 Apr 2026 Sep 2026 $0.321 $0.082
▲ Up 259% over the last 11 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Billing & reimbursement

FDA NDC (as labeled)0409-4887-10
11-digit billing NDC00409-4887-10
Format4-4-2 as registered → padded to 5-4-2 for billing (zero added to the labeler segment)
HCPCS J-codeA4216
DescriptorSTERILE WATER, SALINE AND/OR DEXTROSE, DILUENT/FLUSH, 10 ML
Billing units / pkg0.1 units
How the units are derivedThis package is 10 ML; the HCPCS unit is 10 ML, so one package = 0.1 billing units.
Crosswalk sourcePDAC NDC-HCPCS crosswalk (DME MAC / DMEPOS)
Where does this data come from?
The HCPCS J-code crosswalk comes from the CMS ASP NDC-HCPCS crosswalk and the DMEPDAC (DME MAC) NDC-HCPCS crosswalk — free public CMS data. Billing units are derived from the code’s descriptor and the package amount.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
00409-4887-10 You're viewing this Main listing 25 VIAL, PLASTIC in 1 TRAY / 10 mL in 1 VIAL, PLASTIC $0.3150 / mL $78.75 2005-08-01 — Active
00409-4887-20 0409-4887-20 25 VIAL, PLASTIC in 1 TRAY / 20 mL in 1 VIAL, PLASTIC $0.0661 / mL $33.03 2005-06-16 — Active
00409-4887-34 0409-4887-34 30 VIAL, PLASTIC in 1 TRAY / 10 mL in 1 VIAL, PLASTIC — — 2015-07-30 — Active
00409-4887-50 0409-4887-50 25 VIAL, PLASTIC in 1 TRAY / 50 mL in 1 VIAL, PLASTIC — — 2005-08-04 — Active
00409-4887-99 0409-4887-99 25 VIAL, GLASS in 1 CASE / 100 mL in 1 VIAL, GLASS — — 2005-08-03 — Discontinued by firm

Per mL, this pack runs about 377% above the cheapest pack (NDC 00409-4887-20, $0.0661 vs $0.3150 NADAC).

In Medicaid, this is the most-dispensed pack of this product — about 63% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 25 vial, plastic in 1 tray / 10 ml in 1 vial, plastic.
What NDC number is used to bill for this package of Sterile Water 1 mL/mL Injection?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Sterile Water 1 mL/mLthis 00409-4887-10 Hospira, 25 vials $0.315 — Availability likely —
Sterile Water 1 mL/mL 00409-0024-10 Hospira, 25 vials $0.315 — Availability likely —
Sterile Water 1 mL/mL 63323-0185-05 Fresenius 25 vials — AP FDA listed —
Sterile Water 1 mL/mL 65219-0187-10 Fresenius 25 vials — AP FDA listed —
Sterile Water 1 mL/mL 76420-0082-10 Asclemed 10 ml — — FDA listed —
Bacteriostatic Water 1 mL/mL 71872-7129-01 Medical 1 vial — AP FDA listed —
Sterile Water 1 mL/mL 72572-0747-10 Civica, 10 vials — AP FDA listed —
Sterile Water 1 mL/mL 00404-9971-00 Henry 1 vial — — FDA listed —
Sterile Water 1 mL/mL 50090-2874-01 A-S 25 vials — — FDA listed —
Sterile Water 1 mL/mL 55154-9588-05 Cardinal 5 vials — AP FDA listed —
Sterile Water 1 mL/mL 00641-6147-10 Hikma 10 vials — AP FDA listed —
Sterile Water 1 mL/mL 00404-9959-10 Henry 1 vial — — FDA listed —
Sterile Water 1 mL/mL 55154-0127-05 Cardinal 5 vials — — FDA listed —
Sterile Water 1 mL/mL 84549-0887-50 ProPharma 50 ml — — FDA listed —
Bacteriostatic Water 1 mL/mL 00404-9970-30 Henry 1 vial — AP FDA listed —
Sterile Water 1 mL/mL 71872-7290-01 Medical 1 vial — — FDA listed —
Sterile Water 1 mL/mL 70518-4732-01 REMEDYREPACK 25 vials — — FDA listed —
About this product: this is the brand-name version. FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2005
On the market since
Jun 2005
📍
2026
Currently FDA-listed
21 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Water inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

A current SPL was checked, but it does not contain a structured or narrative inactive-ingredient list for this product. This does not mean the product has no inactive ingredients.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerHospira, Inc.
Application holderHOSPIRA INC
FDA applicationNDA018801 (NDA)
Labeler code00409
First marketedJun 2005
Product typeHuman Prescription Drug
Portfolio317 products on file

More NDCs from Hospira, Inc. labeler code 00409

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⛔ Contraindications ⚠️ Warnings 🤒 Adverse Reactions 🆘 Overdosage 🧬 Clinical Pharmacology 📦 How Supplied / Storage and Handling 📋 Description ⚠️ Precautions 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 32 words ▾

INDICATIONS AND USAGE This parenteral preparation is indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered.

⏱️ Dosage and Administration 54 words ▾

DOSAGE AND ADMINISTRATION The volume of the preparation to be used for diluting or dissolving any drug for injection is dependent on the vehicle concentration, dose and route of administration as recommended by the manufacturer. This parenteral should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

⛔ Contraindications 14 words ▾

CONTRAINDICATIONS Sterile Water for Injection, USP must be made approximately isotonic prior to use.

⚠️ Warnings 15 words ▾

WARNINGS Intravenous administration of Sterile Water for Injection without a solute may result in hemolysis.

🤒 Adverse Reactions 75 words ▾

ADVERSE REACTIONS Reactions which may occur because of this solution, added drugs or the technique of reconstitution or administration include febrile response, local tenderness, abscess, tissue necrosis or infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection and extravasation. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate countermeasures, and if possible, retrieve and save the remainder of the unused vehicle for examination.

🆘 Overdosage 50 words ▾

OVERDOSAGE Use only as a diluent or solvent. This parenteral preparation is unlikely to pose a threat of fluid overload except possibly in neonates or very small infants. In the event these should occur, re-evaluate the patient and institute appropriate corrective measures. See WARNINGS , PRECAUTIONS and ADVERSE REACTIONS .

🧬 Clinical Pharmacology 125 words ▾

CLINICAL PHARMACOLOGY Water is an essential constituent of all body tissues and accounts for approximately 70% of total body weight. Average normal adult daily requirement ranges from two to three liters (1.0 to 1.5 liters each for insensible water loss by perspiration and urine production). Water balance is maintained by various regulatory mechanisms.

Water for distribution depends primarily on the concentration of electrolytes in the body compartments and sodium (Na + ) plays a major role in maintaining physiologic equilibrium. The small volume of fluid provided by Sterile Water for Injection, USP when used only as a pharmaceutic aid for diluting or dissolving drugs for parenteral injection, is unlikely to exert a significant effect on fluid balance except possibly in neonates or very small infants.

📦 How Supplied / Storage and Handling 125 words ▾

HOW SUPPLIED Sterile Water for Injection, USP is a sterile, clear, and colorless water for injection, available as a single-dose vial, and is supplied in the following: Unit of Sale Total Content NDC 0409-4887-05 Tray of 25 Single-dose Glass Fliptop Vials 1 mL NDC 0409-4887-10 Tray of 25 Single-dose Plastic Fliptop Vials 10 mL NDC 0409-4887-34 Tray of 30 Single-dose Plastic Fliptop Vials 10 mL NDC 0409-4887-20 Tray of 25 Single-dose Plastic Fliptop Vials 20 mL NDC 0409-4887-50 Tray of 25 Single-dose Plastic Fliptop Vials 50 mL NDC 0409-4887-99 Case of 25 Single-dose Glass Fliptop Vials 100 mL Store at 20°C to 25°C (68°F to 77°F). [See USP Controlled Room Temperature.] Distributed by Hospira, Inc., Lake Forest, IL 60045 USA LAB-1292-4.0 Revised: 03/2026 Hospira logo

📋 Description 161 words ▾

DESCRIPTION This preparation is designed solely for parenteral use only after addition of drugs that require dilution or must be dissolved in an aqueous vehicle prior to injection. Sterile Water for Injection, USP is a sterile, nonpyrogenic preparation of water for injection which contains no bacteriostat, antimicrobial agent or added buffer and is supplied only in single-dose containers to dilute or dissolve drugs for injection. For I.V. injection, add sufficient solute to make an approximately isotonic solution.

Water for Injection, USP is chemically designated H 2 O. The glass vial is Type I or II borosilicate glass and meets the requirements of the powdered glass test according to the USP standards. The semi-rigid vial is fabricated from a specially formulated polyolefin.

It is a copolymer of ethylene and propylene. The safety of the plastic has been confirmed by tests in animals according to USP biological standards for plastic containers. The container requires no vapor barrier to maintain the proper labeled volume.

⚠️ Precautions ~1 min read ▾

PRECAUTIONS Do not use for intravenous injection unless the osmolar concentration of additives results in an approximate isotonic admixture. Consult the manufacturer's instructions for choice of vehicle, appropriate dilution or volume for dissolving the drugs to be injected, including the route and rate of injection. Inspect reconstituted (diluted or dissolved) drugs for clarity (if soluble) and freedom from unexpected precipitation or discoloration prior to administration.

Pregnancy: Animal reproduction studies have not been conducted with Sterile Water for Injection. It is also not known whether sterile water containing additives can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Sterile Water for Injection with additives should be given to a pregnant woman only if clearly needed.

Pediatric Use Safety and effectiveness have been established in pediatric patients. However, in neonates or very small infants the volume of fluid may affect fluid and electrolyte balance. Drug Interactions Some drugs for injection may be incompatible in a given vehicle, or when combined in the same vehicle or in a vehicle containing benzyl alcohol.

Consult with pharmacist, if available. Use aseptic technique for single or multiple entry and withdrawal from all containers. When diluting or dissolving drugs, mix thoroughly and use promptly.

Do not store reconstituted solutions of drugs for injection unless otherwise directed by the manufacturer of the solute. Do not use unless the solution is clear and seal intact. Do not reuse single-dose containers.

Discard unused portion.

📄 Package Label / Principal Display Panel ~2 min read ▾

PRINCIPAL DISPLAY PANEL - 100 mL Vial Label 100 mL Single-dose WARNINGS: NOT ISOTONIC. HEMOLYTIC. Sterile Water For Inj., USP FOR DRUG DILUENT USE ONLY Distributed by Hospira, Inc., Lake Forest, IL 60045 USA LOT ##-###-AA EXP DMMMYYYY PRINCIPAL DISPLAY PANEL - 100 mL Vial Label

PRINCIPAL DISPLAY PANEL - 1 mL Vial Label 1 mL Fill Single-dose Sterile Water for Injection, USP Rx only Hospira Hospira, Inc., Lake Forest, IL 60045 USA PRINCIPAL DISPLAY PANEL - 1 mL Vial Label

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label - NDC 0409-4887-17 10 mL Single-dose Sterile Water for Injection, USP FOR DRUG DILUENT USE LOT ##-###-AA EXP DMMMYYYY PRINCIPAL DISPLAY PANEL - 10 mL Vial Label - NDC 0409-4887-17

PRINCIPAL DISPLAY PANEL - 10 mL Vial Tray - NDC 0409-4887-10 10 mL Single-dose Rx only NDC 0409-4887-10 Contains 25 of NDC 0409-4887-17 Sterile Water for Injection, USP FOR DRUG DILUENT USE Hospira PRINCIPAL DISPLAY PANEL - 10 mL Vial Tray - NDC 0409-4887-10

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label - NDC 0409-4887-32 10 mL Single-dose Sterile Water for Inj., USP Rx only Hospira LOT ##-###-AA EXP DMMMYYYY PRINCIPAL DISPLAY PANEL - 10 mL Vial Label - NDC 0409-4887-32

PRINCIPAL DISPLAY PANEL - 10 mL Vial Tray - NDC 0409-4887-34 10 mL Single-dose Rx only NDC 0409-4887-34 Contains 30 of NDC 0409-4887-32 Sterile Water for Injection, USP FOR DRUG DILUENT USE Hospira PRINCIPAL DISPLAY PANEL - 10 mL Vial Tray - NDC 0409-4887-34

PRINCIPAL DISPLAY PANEL - 20 mL Vial Label 20 mL Single-dose Sterile Water for Injection, USP FOR DRUG DILUENT USE LOT ##-###-AA EXP DMMMYYYY PRINCIPAL DISPLAY PANEL - 20 mL Vial Label

PRINCIPAL DISPLAY PANEL - 20 mL Vial Tray 20 mL Single-dose Rx only NDC 0409-4887-20 Contains 25 of NDC 0409-4887-23 Sterile Water for Injection, USP FOR DRUG DILUENT USE Hospira PRINCIPAL DISPLAY PANEL - 20 mL Vial Tray

PRINCIPAL DISPLAY PANEL - 50 mL Vial Label 50 mL Single-dose Sterile Water for Injection, USP FOR DRUG DILUENT USE LOT ##-###-AA EXP DMMMYYYY PRINCIPAL DISPLAY PANEL - 50 mL Vial Label

PRINCIPAL DISPLAY PANEL - 50 mL Vial Tray 50 mL Single-dose Rx only NDC 0409-4887-50 Contains 25 of NDC 0409-4887-24 Sterile Water for Injection, USP FOR DRUG DILUENT USE Hospira PRINCIPAL DISPLAY PANEL - 50 mL Vial Tray

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
16.9K
Units reimbursed last 4 qtrs
2.7M
Gross reimbursed last 4 qtrs
$11.41M
Avg / prescription
$675.43
Avg / unit
$4.2884
Latest quarter Q1 2026
3.9KRx
Medicaid pays / mL
$4.2884
gross reimbursed
vs
NADAC / mL
$0.3150
acquisition cost
=
Spread
+$3.9734
+1261% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
60% FFS 40% MCO
Fee-for-service · 10,197 Rx Managed care · 6,691 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: 8,133 units · 104 per 100k residents WA Idaho: no data reported ID Montana: no data reported MT North Dakota: 450 units · 57.5 per 100k residents ND Minnesota: 4,943 units · 86.2 per 100k residents MN Wisconsin: 14,192 units · 240 per 100k residents WI Michigan: 14,600 units · 145 per 100k residents MI New York: 4,312 units · 22.0 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: 8,450 units · 200 per 100k residents OR Nevada: 1,960 units · 61.4 per 100k residents NV Wyoming: no data reported WY South Dakota: 1,368 units · 149 per 100k residents SD Iowa: no data reported IA Illinois: 68,047 units · 542 per 100k residents IL Indiana: 5,555 units · 81.0 per 100k residents IN Ohio: 100,276 units · 851 per 100k residents OH Pennsylvania: 46,075 units · 355 per 100k residents PA New Jersey: 9,576 units · 103 per 100k residents NJ Massachusetts: 39,991 units · 571 per 100k residents MA California: 1,777,268 units · 4,561 per 100k residents CA Utah: 2,870 units · 84.0 per 100k residents UT Colorado: 11,745 units · 200 per 100k residents CO Nebraska: 836 units · 42.3 per 100k residents NE Missouri: 15,732 units · 254 per 100k residents MO Kentucky: 51,165 units · 1,130 per 100k residents KY West Virginia: 3,291 units · 186 per 100k residents WV Virginia: 19,337 units · 222 per 100k residents VA Maryland: 4,746 units · 76.8 per 100k residents MD Connecticut: 14,571 units · 403 per 100k residents CT Rhode Island: no data reported RI Arizona: 760 units · 10.2 per 100k residents AZ New Mexico: 199 units · 9.4 per 100k residents NM Kansas: 5,234 units · 178 per 100k residents KS Arkansas: 1,870 units · 61.0 per 100k residents AR Tennessee: 244,900 units · 3,437 per 100k residents TN North Carolina: 68,891 units · 636 per 100k residents NC South Carolina: 16,603 units · 309 per 100k residents SC Delaware: no data reported DE Oklahoma: 570 units · 14.1 per 100k residents OK Louisiana: 7,743 units · 169 per 100k residents LA Mississippi: 1,792 units · 61.0 per 100k residents MS Alabama: 7,497 units · 147 per 100k residents AL Georgia: 1,065 units · 9.7 per 100k residents GA D.C.: 18 units · 2.7 per 100k residents DC Hawaii: no data reported HI Texas: 640 units · 2.1 per 100k residents TX Florida: 72,616 units · 321 per 100k residents FL
Units reimbursed · per 100k residents
2.14,561
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 California 4,561 /100k
2 Tennessee 3,437 /100k
3 Kentucky 1,130 /100k
4 Ohio 851 /100k
5 North Carolina 636 /100k
6 Massachusetts 571 /100k
7 Illinois 542 /100k
8 Connecticut 403 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
25 vials this page00409-4887-10 16,888 Rx · $11,406,665
25 vials00409-4887-20 6,605 Rx · $6,379,430
25 vials00409-4887-50 2,310 Rx · $154,043
25 vials00409-4887-99 821 Rx · $219,172
30 vials00409-4887-34 No Medicaid data
Drug total (last 4 qtrs): 26,624 Rx · 3,762,668 units · $18,159,310 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.
← 00409-4883-01 · Hospira, 00409-4888-10 · Hospira, →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.